Cargando…
Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy
BACKGROUND: Considering the narrow immune response spectrum of a single epitope, and the nanoparticles (NPs) as a novel adjuvant can achieve efficient delivery of antigenic peptides safely, a nano-system (denoted as DSPE-PEG-Man@EM-NPs) based on cathepsin B-responsive antigenic peptides was designed...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183215/ https://www.ncbi.nlm.nih.gov/pubmed/34083420 http://dx.doi.org/10.1136/jitc-2021-002523 |
_version_ | 1783704338979356672 |
---|---|
author | Shi, Wei Qiu, Qianqian Feng, Ziying Tong, Zhenzhen Guo, Weiwei Zou, Feng Yue, Na Huang, Wenlong Qian, Hai |
author_facet | Shi, Wei Qiu, Qianqian Feng, Ziying Tong, Zhenzhen Guo, Weiwei Zou, Feng Yue, Na Huang, Wenlong Qian, Hai |
author_sort | Shi, Wei |
collection | PubMed |
description | BACKGROUND: Considering the narrow immune response spectrum of a single epitope, and the nanoparticles (NPs) as a novel adjuvant can achieve efficient delivery of antigenic peptides safely, a nano-system (denoted as DSPE-PEG-Man@EM-NPs) based on cathepsin B-responsive antigenic peptides was designed and synthesized. METHODS: Highly affinitive antigenic peptides were delivered by self-assembled NPs, and targeted erythrocyte membranes acted as a peptide carrier to improve antigenic peptides presentation and to strengthen cytotoxic T-cells reaction. Cathepsin B coupling could release antigenic peptides rapidly in dendritic cells. RESULTS: Evaluations showed that DSPE-PEG-Man@EM-NPs had obvious inhibitory effects towards both MCF-7 and MDA-MB-231 human breast cancer cell lines. CONCLUSION: Overall, this strategy provides a novel strategy for boosting cytotoxic T lymphocytes response, thereby expanding the adaptation range of tumor antigenic peptides and improving the therapeutic effect of tumor immunotherapy with nanomedicine. |
format | Online Article Text |
id | pubmed-8183215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-81832152021-06-17 Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy Shi, Wei Qiu, Qianqian Feng, Ziying Tong, Zhenzhen Guo, Weiwei Zou, Feng Yue, Na Huang, Wenlong Qian, Hai J Immunother Cancer Basic Tumor Immunology BACKGROUND: Considering the narrow immune response spectrum of a single epitope, and the nanoparticles (NPs) as a novel adjuvant can achieve efficient delivery of antigenic peptides safely, a nano-system (denoted as DSPE-PEG-Man@EM-NPs) based on cathepsin B-responsive antigenic peptides was designed and synthesized. METHODS: Highly affinitive antigenic peptides were delivered by self-assembled NPs, and targeted erythrocyte membranes acted as a peptide carrier to improve antigenic peptides presentation and to strengthen cytotoxic T-cells reaction. Cathepsin B coupling could release antigenic peptides rapidly in dendritic cells. RESULTS: Evaluations showed that DSPE-PEG-Man@EM-NPs had obvious inhibitory effects towards both MCF-7 and MDA-MB-231 human breast cancer cell lines. CONCLUSION: Overall, this strategy provides a novel strategy for boosting cytotoxic T lymphocytes response, thereby expanding the adaptation range of tumor antigenic peptides and improving the therapeutic effect of tumor immunotherapy with nanomedicine. BMJ Publishing Group 2021-06-03 /pmc/articles/PMC8183215/ /pubmed/34083420 http://dx.doi.org/10.1136/jitc-2021-002523 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Basic Tumor Immunology Shi, Wei Qiu, Qianqian Feng, Ziying Tong, Zhenzhen Guo, Weiwei Zou, Feng Yue, Na Huang, Wenlong Qian, Hai Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy |
title | Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy |
title_full | Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy |
title_fullStr | Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy |
title_full_unstemmed | Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy |
title_short | Design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy |
title_sort | design, synthesis and immunological evaluation of self-assembled antigenic peptides from dual-antigen targets: a broad-spectrum candidate for an effective antibreast cancer therapy |
topic | Basic Tumor Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183215/ https://www.ncbi.nlm.nih.gov/pubmed/34083420 http://dx.doi.org/10.1136/jitc-2021-002523 |
work_keys_str_mv | AT shiwei designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy AT qiuqianqian designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy AT fengziying designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy AT tongzhenzhen designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy AT guoweiwei designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy AT zoufeng designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy AT yuena designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy AT huangwenlong designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy AT qianhai designsynthesisandimmunologicalevaluationofselfassembledantigenicpeptidesfromdualantigentargetsabroadspectrumcandidateforaneffectiveantibreastcancertherapy |